Drugs / NEUMOTEROL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02233803 | Nov 2014 → Dec 2015 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NEUMOTEROL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02233803 ↗ |
| Known as | BFF | “Budesonide/Formoterol Fumarate combination (BFF) 400/12 micrograms (mcg) single capsule inhaler (NEUMOTEROL 400)” NCT02233803 ↗ |
| Route | Inhaled | “per capsule dispensed by single capsule inhaler” NCT02233803 ↗ |